Broadway Wealth Solutions’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
1,706
+10
+0.6% +$1.17K 0.1% 85
2026
Q1
$204K Buy
+1,696
New +$196K 0.11% 92
2025
Q4
Sell
-2,422
Closed -$203K 98
2025
Q3
$203K Sell
2,422
-3,917
-62% -$323K 0.11% 94
2025
Q2
$502K Buy
6,339
+876
+16% +$69.6K 0.31% 29
2025
Q1
$490K Sell
5,463
-183
-3% -$17.1K 0.36% 24
2024
Q4
$562K Buy
+5,646
New +$582K 0.43% 24

Other funds holding MRK

Broadway Wealth Solutions's MRK Position: Q2 2026 in Review

Broadway Wealth Solutions increased its Merck (MRK) stake by 0.59% in Q2 2026, buying an estimated $1.17K and bringing the position to 1,706 shares worth $219K. The position accounts for 0.1% of the portfolio, ranked #85.

Broadway Wealth Solutions first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $562K in Q4 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Broadway Wealth Solutions held 1,706 shares of Merck worth $219K as of Q2 2026.
  • Broadway Wealth Solutions bought 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.1% of Broadway Wealth Solutions's portfolio in Q2 2026, its #85 holding.
  • Broadway Wealth Solutions first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Broadway Wealth Solutions's Merck position peaked at $562K in Q4 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Broadway Wealth Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.